purchase customization

Leave This Empty:

choose chapter to purchase

table of content

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Viral Vectors
1.2 Key Market Segments
1.2.1 Viral Vectors Segment by Type
1.2.2 Viral Vectors Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Viral Vectors Market Overview
2.1 Global Market Overview
2.1.1 Global Viral Vectors Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Viral Vectors Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Viral Vectors Market Competitive Landscape
3.1 Global Viral Vectors Sales by Manufacturers (2019-2024)
3.2 Global Viral Vectors Revenue Market Share by Manufacturers (2019-2024)
3.3 Viral Vectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Viral Vectors Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Viral Vectors Sales Sites, Area Served, Product Type
3.6 Viral Vectors Market Competitive Situation and Trends
3.6.1 Viral Vectors Market Concentration Rate
3.6.2 Global 5 and 10 Largest Viral Vectors Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Viral Vectors Industry Chain Analysis
4.1 Viral Vectors Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Viral Vectors Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Viral Vectors Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viral Vectors Sales Market Share by Type (2019-2024)
6.3 Global Viral Vectors Market Size Market Share by Type (2019-2024)
6.4 Global Viral Vectors Price by Type (2019-2024)
7 Viral Vectors Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viral Vectors Market Sales by Application (2019-2024)
7.3 Global Viral Vectors Market Size (M USD) by Application (2019-2024)
7.4 Global Viral Vectors Sales Growth Rate by Application (2019-2024)
8 Viral Vectors Market Segmentation by Region
8.1 Global Viral Vectors Sales by Region
8.1.1 Global Viral Vectors Sales by Region
8.1.2 Global Viral Vectors Sales Market Share by Region
8.2 North America
8.2.1 North America Viral Vectors Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Viral Vectors Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Viral Vectors Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Viral Vectors Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Viral Vectors Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 BioReliance
9.1.1 BioReliance Viral Vectors Basic Information
9.1.2 BioReliance Viral Vectors Product Overview
9.1.3 BioReliance Viral Vectors Product Market Performance
9.1.4 BioReliance Business Overview
9.1.5 BioReliance Viral Vectors SWOT Analysis
9.1.6 BioReliance Recent Developments
9.2 Cobra Biologics
9.2.1 Cobra Biologics Viral Vectors Basic Information
9.2.2 Cobra Biologics Viral Vectors Product Overview
9.2.3 Cobra Biologics Viral Vectors Product Market Performance
9.2.4 Cobra Biologics Business Overview
9.2.5 Cobra Biologics Viral Vectors SWOT Analysis
9.2.6 Cobra Biologics Recent Developments
9.3 Oxford BioMedica
9.3.1 Oxford BioMedica Viral Vectors Basic Information
9.3.2 Oxford BioMedica Viral Vectors Product Overview
9.3.3 Oxford BioMedica Viral Vectors Product Market Performance
9.3.4 Oxford BioMedica Viral Vectors SWOT Analysis
9.3.5 Oxford BioMedica Business Overview
9.3.6 Oxford BioMedica Recent Developments
9.4 UniQure
9.4.1 UniQure Viral Vectors Basic Information
9.4.2 UniQure Viral Vectors Product Overview
9.4.3 UniQure Viral Vectors Product Market Performance
9.4.4 UniQure Business Overview
9.4.5 UniQure Recent Developments
9.5 FinVector
9.5.1 FinVector Viral Vectors Basic Information
9.5.2 FinVector Viral Vectors Product Overview
9.5.3 FinVector Viral Vectors Product Market Performance
9.5.4 FinVector Business Overview
9.5.5 FinVector Recent Developments
9.6 MolMed
9.6.1 MolMed Viral Vectors Basic Information
9.6.2 MolMed Viral Vectors Product Overview
9.6.3 MolMed Viral Vectors Product Market Performance
9.6.4 MolMed Business Overview
9.6.5 MolMed Recent Developments
9.7 MassBiologics
9.7.1 MassBiologics Viral Vectors Basic Information
9.7.2 MassBiologics Viral Vectors Product Overview
9.7.3 MassBiologics Viral Vectors Product Market Performance
9.7.4 MassBiologics Business Overview
9.7.5 MassBiologics Recent Developments
9.8 Richter-Helm
9.8.1 Richter-Helm Viral Vectors Basic Information
9.8.2 Richter-Helm Viral Vectors Product Overview
9.8.3 Richter-Helm Viral Vectors Product Market Performance
9.8.4 Richter-Helm Business Overview
9.8.5 Richter-Helm Recent Developments
9.9 FUJIFILM Diosynth Biotechnologies
9.9.1 FUJIFILM Diosynth Biotechnologies Viral Vectors Basic Information
9.9.2 FUJIFILM Diosynth Biotechnologies Viral Vectors Product Overview
9.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors Product Market Performance
9.9.4 FUJIFILM Diosynth Biotechnologies Business Overview
9.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.10 Lonza
9.10.1 Lonza Viral Vectors Basic Information
9.10.2 Lonza Viral Vectors Product Overview
9.10.3 Lonza Viral Vectors Product Market Performance
9.10.4 Lonza Business Overview
9.10.5 Lonza Recent Developments
9.11 Aldevron
9.11.1 Aldevron Viral Vectors Basic Information
9.11.2 Aldevron Viral Vectors Product Overview
9.11.3 Aldevron Viral Vectors Product Market Performance
9.11.4 Aldevron Business Overview
9.11.5 Aldevron Recent Developments
9.12 Eurogentec
9.12.1 Eurogentec Viral Vectors Basic Information
9.12.2 Eurogentec Viral Vectors Product Overview
9.12.3 Eurogentec Viral Vectors Product Market Performance
9.12.4 Eurogentec Business Overview
9.12.5 Eurogentec Recent Developments
9.13 Cell and Gene Therapy Catapult
9.13.1 Cell and Gene Therapy Catapult Viral Vectors Basic Information
9.13.2 Cell and Gene Therapy Catapult Viral Vectors Product Overview
9.13.3 Cell and Gene Therapy Catapult Viral Vectors Product Market Performance
9.13.4 Cell and Gene Therapy Catapult Business Overview
9.13.5 Cell and Gene Therapy Catapult Recent Developments
9.14 Biovian
9.14.1 Biovian Viral Vectors Basic Information
9.14.2 Biovian Viral Vectors Product Overview
9.14.3 Biovian Viral Vectors Product Market Performance
9.14.4 Biovian Business Overview
9.14.5 Biovian Recent Developments
9.15 Thermo Fisher Scientific (Brammer Bio)
9.15.1 Thermo Fisher Scientific (Brammer Bio) Viral Vectors Basic Information
9.15.2 Thermo Fisher Scientific (Brammer Bio) Viral Vectors Product Overview
9.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors Product Market Performance
9.15.4 Thermo Fisher Scientific (Brammer Bio) Business Overview
9.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Developments
9.16 VGXI
9.16.1 VGXI Viral Vectors Basic Information
9.16.2 VGXI Viral Vectors Product Overview
9.16.3 VGXI Viral Vectors Product Market Performance
9.16.4 VGXI Business Overview
9.16.5 VGXI Recent Developments
9.17 PlasmidFactory
9.17.1 PlasmidFactory Viral Vectors Basic Information
9.17.2 PlasmidFactory Viral Vectors Product Overview
9.17.3 PlasmidFactory Viral Vectors Product Market Performance
9.17.4 PlasmidFactory Business Overview
9.17.5 PlasmidFactory Recent Developments
10 Viral Vectors Market Forecast by Region
10.1 Global Viral Vectors Market Size Forecast
10.2 Global Viral Vectors Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Viral Vectors Market Size Forecast by Country
10.2.3 Asia Pacific Viral Vectors Market Size Forecast by Region
10.2.4 South America Viral Vectors Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Viral Vectors by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Viral Vectors Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Viral Vectors by Type (2025-2030)
11.1.2 Global Viral Vectors Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Viral Vectors by Type (2025-2030)
11.2 Global Viral Vectors Market Forecast by Application (2025-2030)
11.2.1 Global Viral Vectors Sales (K Units) Forecast by Application
11.2.2 Global Viral Vectors Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings